ATC代碼A10(糖尿病用藥)是解剖學治療學及化學分類系統的一個藥物分組,這是由世界衛生組織藥物統計方法整合中心(The WHO Collaborating Centre for Drug Statistics Methodology)所制定的藥品及其它醫用產品的官方分類系統。分組A10是A消化系統和代謝系統的一部分。[1]
Quick Facts ATC代碼 ...
ATC代碼
|
A 消化系統和代謝系統
|
A01 口腔病藥物 (Stomatological preparations)
|
A02 治療與胃酸分泌相關疾病的藥物 (Drugs for acid related disorders)
|
A03 腸胃機能失調用藥 (Drugs for functional gastrointestinal disorders)
|
A04 止吐藥及止噁心藥 (Antiemetics and antinauseants)
|
A05 肝、膽疾病治療藥 (Bile and liver therapy)
|
A06 輕瀉藥 (Laxatives)
|
A07 止瀉藥、腸道消炎藥、腸道抗感染藥 (Antidiarrheals, intestinal anti-inflammatory /anti-infective agents)
|
A08 減肥製劑,不包含飲食製品 (Antiobesity preparations, excluding diet products)
|
A09 消化藥,包括酶 (Digestives, including enzymes)
|
A10 糖尿病用藥 (Drugs used in diabetes)
|
A11 維生素 (Vitamins)
|
A12 礦物補充劑 (Mineral supplements)
|
A13 補藥 (Tonic)
|
A14 同化作用藥 (Anabolic agents for systemic use)
|
A15 食慾促進劑 (Appetite stimulants)
|
A16 其它消化道及新陳代謝用藥 (Other alimentary tract and metabolism products)
|
A·B·C·D·G·H·QI·J·L·M·N·P·R·S·V
|
Close
獸用代碼(ATCvet碼)可以在人用ATC代碼前加Q字母:QA10等[2]。
國家ATC分類可能包括列表中沒有的其它分類,列表為世界衛生組織(WHO)版本。
- A10AB01 人胰島素(Insulin (human))
- A10AB02 牛胰島素(Insulin (beef))
- A10AB03 豬胰島素(Insulin (pork))
- A10AB04 賴脯胰島素(Insulin lispro)
- A10AB05 門冬胰島素(Insulin aspart)
- A10AB06 賴谷胰島素(Insulin glulisine)
- A10AB30 複方(Combinations)
- A10AC01 人胰島素(Insulin (human))
- A10AC02 牛胰島素(Insulin (beef))
- A10AC03 豬胰島素(Insulin (pork))
- A10AC04 賴脯胰島素(Insulin lispro)
- A10AC30 複方(Combinations)
- A10AD01 人胰島素(Insulin (human))
- A10AD02 牛胰島素(Insulin (beef))
- A10AD03 豬胰島素(Insulin (pork))
- A10AD04 賴脯胰島素(Insulin lispro)
- A10AD05 門冬胰島素(Insulin aspart)
- A10AD30 複方(Combinations)
- A10AE01 人胰島素(Insulin (human))
- A10AE02 牛胰島素(Insulin (beef))
- A10AE03 豬胰島素(Insulin (pork))
- A10AE04 甘精胰島素(Insulin glargine)
- A10AE05 地特胰島素(Insulin detemir)
- A10AE30 複方(Combinations)
- A10AF01 人胰島素(Insulin (human))
- A10BA01 苯乙雙胍(Phenformin)
- A10BA02 二甲雙胍(Metformin)
- A10BA03 丁福明(Buformin)
- A10BB01 格列本脲(Glibenclamide)
- A10BB02 氯磺丙脲(Chlorpropamide)
- A10BB03 甲磺丁脲(Tolbutamide)
- A10BB04 格列波脲(Glibornuride)
- A10BB05 妥拉磺脲(Tolazamide)
- A10BB06 氨磺丁脲(Carbutamide)
- A10BB07 格列吡嗪(Glipizide)
- A10BB08 格列喹酮(Gliquidone)
- A10BB09 格列齊特(Gliclazide)
- A10BB10 美他己脲(Metahexamide)
- A10BB11 格列派特(Glisoxepide)
- A10BB12 格列美脲(Glimepiride)
- A10BB31 醋酸己脲(Acetohexamide)
- A10BD01 苯乙雙胍和磺胺類(Phenformin and sulfonamides)
- A10BD02 二甲雙胍和磺胺類(Metformin and sulfonamides)
- A10BD03 二甲雙胍和羅格列酮(Metformin and rosiglitazone)
- A10BD04 格列美脲和羅格列酮(Glimepiride and rosiglitazone)
- A10BD05 二甲雙胍和吡格列酮(Metformin and pioglitazone)
- A10BD06 格列美脲和吡格列酮(Glimepiride and pioglitazone)
- A10BD07 二甲雙胍和西格列汀(Metformin and sitagliptin)
- A10BD08 二甲雙胍和維格列汀(Metformin and vildagliptin)
- A10BD09 吡格列酮和阿格列汀(Pioglitazone and alogliptin)
- A10BD10 二甲雙胍和沙格列汀(Metformin and saxagliptin)
- A10BD11 二甲雙胍和利拉利汀(Metformin and linagliptin)
- A10BF01 阿卡波糖(Acarbose)
- A10BF02 米格列醇(Miglitol)
- A10BF03 伏格列波糖(Voglibose)
- A10BG01 曲格列酮(Troglitazone)
- A10BG02 羅格列酮(Rosiglitazone)
- A10BG03 吡格列酮(Pioglitazone)
- A10BH01 西格列汀(Sitagliptin)
- A10BH02 維格列汀(Vildagliptin)
- A10BH03 沙格列汀(Saxagliptin)
- A10BH04 阿格列汀(Alogliptin)
- A10BH05 利拉利汀(Linagliptin)
- A10BJ01 艾塞那肽 exenatide
- A10BJ02 利拉魯肽 liraglutide
- A10BJ03 lixisenatide
- A10BJ04 albiglutide
- A10BJ05 dulaglutide
- A10BJ06 semaglutide
- A10BK01 達格列淨 dapagliflozin
- A10BK02 canagliflozin
- A10BK03 恩格列淨 empagliflozin
- A10BX01 瓜耳樹膠(Guar gum)
- A10BX02 瑞格列奈(Repaglinide)
- A10BX03 那格列奈(Nateglinide)
- A10BX05 普蘭林肽(Pramlintide)
- A10BX06 苯氟雷司(Benfluorex)
- A10BX08 米格列奈(Mitiglinide)
ATC Index. WHO Collaborating Centre for Drug Statistics Methodology.
ATCvet Index. WHO Collaborating Centre for Drug Statistics Methodology.